Hideyasu Matsuyama

13PUBLICATIONS
47CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 15, 2026
Reviewer's Comment on Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non-Muscle Invasive Bladder Cancer.

|Jan 12, 2026
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study.

Atsushi Mizokami, Rikiya Matsumoto, Hideaki Miyake

|May 17, 2024
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study.

Tokiyoshi Tanegashima, Masaki Shiota, Nobuhiro Fujiyama

|Oct 09, 2023
Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance.

Nobuaki Matsubara, Hideyasu Matsuyama, Hirotaka Kazama

|Jul 27, 2023
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study.

Hiroyuki Nishiyama, Toyonori Tsuzuki, Chikara Ohyama

|Dec 09, 2022
A Phase II Trial of Abiraterone With Dutasteride for Second-Generation Antiandrogen- and Chemotherapy-Naïve Patients With Castration-Resistant Prostate Cancer.

Masaki Shiota, Ryo Inoue, Kojiro Tashiro

Pageof 3

Frequent Collaborators

5 joint publications

Hiroaki Matsumoto

3 joint publications

Masaki Shiota

2 joint publications

Atsushi Mizokami

2 joint publications

Keita Kobayashi